» Articles » PMID: 34491882

Gut Microbiota Associations with Metabolic Syndrome and Relevance of Its Study in Pediatric Subjects

Overview
Journal Gut Microbes
Date 2021 Sep 7
PMID 34491882
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood obesity and T2DM have shown a recent alarming increase due to important changes in global lifestyle and dietary habits, highlighting the need for urgent and novel solutions to improve global public health. Gut microbiota has been shown to be relevant in human health and its dysbiosis has been associated with MetS, a health condition linked to the onset of relevant diseases including T2DM. Even though there have been recent improvements in the understanding of gut microbiota-host interactions, pediatric gut microbiota has been poorly studied compared to adults. This review provides an overview of MetS and its relevance in school-age children, discusses gut microbiota and its possible association with this metabolic condition including relevant emerging gut microbiome-based interventions for its prevention and treatment, and outlines future challenges and perspectives in preventing microbiota dysbiosis from the early stages of life.

Citing Articles

Benzo(a)pyrene and Gut Microbiome Crosstalk: Health Risk Implications.

Mauliasari I, Lee H, Koo S, Hitayezu E, Kieu A, Lee S Toxics. 2025; 12(12).

PMID: 39771153 PMC: 11840287. DOI: 10.3390/toxics12120938.


Comparative analysis of gut microbiota in metabolic syndrome and obese children from Southeastern China.

Wang J, Zhuang P, Lin B, Zheng J, Li H, Tang W Front Microbiol. 2025; 15:1503302.

PMID: 39764447 PMC: 11701008. DOI: 10.3389/fmicb.2024.1503302.


Metabolic syndrome therapy in pediatric age - between classic and modern. From diets to pipeline drugs.

Frasinariu O, Lupu V, Trandafir L, Streanga V, Jechel E, Bararu-Bojan I Front Nutr. 2024; 11:1475111.

PMID: 39723164 PMC: 11669255. DOI: 10.3389/fnut.2024.1475111.


Protein restriction associated with high fat induces metabolic dysregulation without obesity in juvenile mice.

Joly A, Thoumas J, Lambert A, Caillon E, Leulier F, De Vadder F Nutr Metab (Lond). 2024; 21(1):100.

PMID: 39623461 PMC: 11613590. DOI: 10.1186/s12986-024-00879-9.


Cardio-Metabolic Risk Profile of Women With Endometriosis: A Population-Based Study.

Saei Ghare Naz M, Noroozzadeh M, Ardebili S, Mousavi M, Azizi F, Ramezani Tehrani F Endocrinol Diabetes Metab. 2024; 7(6):e70008.

PMID: 39400459 PMC: 11471882. DOI: 10.1002/edm2.70008.


References
1.
Burgueno J, Abreu M . Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol. 2020; 17(5):263-278. DOI: 10.1038/s41575-019-0261-4. View

2.
Beltowski J, Wojcicka G, Jamroz-Wisniewska A . Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: Implications for the pathogenesis and treatment of diabetes mellitus. Biochem Pharmacol. 2018; 149:60-76. DOI: 10.1016/j.bcp.2018.01.004. View

3.
Gallardo-Becerra L, Cornejo-Granados F, Garcia-Lopez R, Valdez-Lara A, Bikel S, Canizales-Quinteros S . Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children. Microb Cell Fact. 2020; 19(1):61. PMC: 7060530. DOI: 10.1186/s12934-020-01319-y. View

4.
de Groot P, Frissen M, de Clercq N, Nieuwdorp M . Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes. 2017; 8(3):253-267. PMC: 5479392. DOI: 10.1080/19490976.2017.1293224. View

5.
Singer-Englar T, Barlow G, Mathur R . Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019; 13(1):3-15. DOI: 10.1080/17474124.2019.1543023. View